-+ 0.00%
-+ 0.00%
-+ 0.00%

IONIS PHARMACEUTICALS SHARES UP 3.5% PREMARKET AFTER CO RECEIVES FDA BREAKTHROUGH THERAPY DESIGNATION FOR OLEZARSEN FOR SHTG

Reuters·12/01/2025 12:05:44

Please log in to view news